Stock AnalizConcentrix Corp CNXC
Computer Software: Prepackaged Software · data as of November 13, 2026
Concentrix Corp (CNXC) is a technology company listed in the US with a market value of about $2.0B. In the twelve months to August 31, 2026 it had revenue of $10.0B and net income of -$2.4B, a net margin of -24.0%.
Its overall Stock Analiz score is 1.8 out of 5 (weak). The strongest part is shareholder returns (4/5); the weakest is future growth (1/5).
Key numbers: a price to free cash flow of 3.5, 5-year revenue growth of 16% a year, a 5-year average ROIC of 4%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 192% above the current price.
Score: 1.8 / 5
Checks passed
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- 3-year revenue growth above 10% a year
- 5-year revenue growth above 8% a year
- Positive free cash flow
- Pays a dividend
- 20% to 100% of free cash flow returned to shareholders
- Dividend 3 years in a row
Checks not passed
- P/E below 25
- P/E below the industry median
- PEG below 1.5
- Revenue growth above 10% last year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 7 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.0B | $9.8B | $9.6B | $7.1B | $6.3B | $5.6B | $4.7B | $4.7B |
| Net income | -$2.4B | -$1.3B | $251M | $314M | $435M | $406M | $165M | $117M |
| Free cash flow | $575M | $572M | $429M | $497M | $461M | $365M | $336M | $339M |
| EPS (diluted) | $-38.42 | $-20.36 | $3.71 | $5.70 | $8.28 | $7.70 | $3.19 | $2.27 |
| Net margin | -24.0% | -13.0% | 2.6% | 4.4% | 6.9% | 7.3% | 3.5% | 2.5% |
| ROIC | — | -8.7% | 5.2% | 5.1% | 8.5% | 10.6% | 4.8% | 8.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 5 analysts is $32.60, 0% below the current price; targets range from $29.00 to $45.00; the consensus rating is “none”; expected EPS is $11.05 for the fiscal year ending November 30, 2026.
Frequently asked questions
Is Concentrix stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 192% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Concentrix pay a dividend?
Yes. The dividend yield is about 4.52%, and it has paid dividends for 5 years in our data.
Is Concentrix a good stock to buy?
We do not give buy or sell advice. Concentrix scores 1.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.